BMS-690514: Clinical Trials

8 trials of BMS-690514, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 23Completed 3

Follow BMS-690514: new trials by email Literature Review of BMS-690514 trials Research Report on BMS-690514

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response
BMS-690514 - Non-Small-Cell Lung Carcinoma
Phase 2CompletedBristol-Myers Squibb112010-08-012015-10-12
Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer
BMS-690514, Lapatinib, Letrozole - Breast Cancer
Phase 2CompletedBristol-Myers Squibb42010-06-012015-10-12
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC
BMS-690514, Erlotinib - Non Small Cell Lung Cancer
Phase 2CompletedBristol-Myers Squibb1412009-03-012015-10-12
Pharmacokinetics and Metabolism of Radiolabeled BMS-690514 in Healthy Male Subjects
EVRI (BMS-690514) - Cancer
Phase 1CompletedBristol-Myers Squibb172008-01-012008-07-31
Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors
BMS-690514 - Cancer
Phase 1CompletedBristol-Myers Squibb92007-11-012008-10-13
A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
BMS-690514 - Cancer (Solid Tumors)
Phase 1CompletedBristol-Myers Squibb372007-10-012016-09-30
Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX
BMS-690514 / FOLFIRI, BMS-690514 / FOLFOX - Cancer
Phase 1CompletedBristol-Myers Squibb252007-09-012011-11-30
A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors
BMS-690514 - Cancer, Tumor
Phase 1CompletedBristol-Myers Squibb892006-08-012011-01-25

Conditions studied

Neoplasms (5)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Breast Neoplasms (1)

Sponsors

Bristol-Myers Squibb (8)

Countries

United States (5)  ·  Canada (3)  ·  France (3)  ·  Argentina (2)  ·  Japan (2)  ·  Spain (2)  ·  Mexico (1)  ·  Peru (1)  ·  Poland (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Results publications

PMID 22878519, PMID 23490650

NIH funding

2009 (1)